Immutep Statistics
Total Valuation
Immutep has a market cap or net worth of $73.66 million. The enterprise value is $3.74 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Immutep has 1.47 billion shares outstanding. The number of shares has increased by 9.74% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +9.74% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 52.22% |
| Float | 1.23B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.94 |
| Forward PS | 3.70 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.97 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,164.41 |
Financial Efficiency
Return on equity (ROE) is -61.85% and return on invested capital (ROIC) is -38.57%.
| Return on Equity (ROE) | -61.85% |
| Return on Assets (ROA) | -32.10% |
| Return on Invested Capital (ROIC) | -38.57% |
| Return on Capital Employed (ROCE) | -84.46% |
| Weighted Average Cost of Capital (WACC) | 16.84% |
| Revenue Per Employee | $170,472 |
| Profits Per Employee | -$1.81M |
| Employee Count | 31 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.63% in the last 52 weeks. The beta is 2.32, so Immutep's price volatility has been higher than the market average.
| Beta (5Y) | 2.32 |
| 52-Week Price Change | -64.63% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 1.89 |
| Relative Strength Index (RSI) | 38.30 |
| Average Volume (20 Days) | 40,194,305 |
Short Selling Information
The latest short interest is 1.31 million, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 1.31M |
| Short Previous Month | 5.21M |
| Short % of Shares Out | 0.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.41 |
Income Statement
In the last 12 months, Immutep had revenue of $5.28 million and -$55.97 million in losses. Loss per share was -$0.04.
| Revenue | 5.28M |
| Gross Profit | -49.88M |
| Operating Income | -56.44M |
| Pretax Income | -55.97M |
| Net Income | -55.97M |
| EBITDA | -54.96M |
| EBIT | -56.44M |
| Loss Per Share | -$0.04 |
Full Income StatementBalance Sheet
The company has $66.12 million in cash and $806,834 in debt, with a net cash position of $65.31 million or $0.04 per share.
| Cash & Cash Equivalents | 66.12M |
| Total Debt | 806,834 |
| Net Cash | 65.31M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 65.97M |
| Book Value Per Share | 0.04 |
| Working Capital | 61.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.46 million and capital expenditures -$84,662, giving a free cash flow of -$44.49 million.
| Operating Cash Flow | -41.46M |
| Capital Expenditures | -84,662 |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | -189,313 |
| Free Cash Flow | -44.49M |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,068.07% |
| Pretax Margin | -1,059.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Immutep does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.74% |
| Shareholder Yield | -9.74% |
| Earnings Yield | -75.99% |
| FCF Yield | -60.40% |
Analyst Forecast
The average price target for Immutep is $5.50, which is 859.86% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.50 |
| Price Target Difference | 859.86% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 116.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2016. It was a reverse split with a ratio of 1:3.33.
| Last Split Date | Dec 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3.33 |
Scores
Immutep has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 2 |
